您的位置: 首页 > 农业专利 > 详情页

Combinations of anti ErbB antibodies for the treatment of cancer
专利权人:
Michael Sela;Ruth Maron;Bilha Schechter;Yosef Yarden
发明人:
Michael Sela,Yosef Yarden,Bilha Schechter,Ruth Maron
申请号:
US14118243
公开号:
US09040047B2
申请日:
2012.05.16
申请国别(地区):
US
年份:
2015
代理人:
摘要:
An article-of-manufacture is provided. The article-of-manufacture comprises a packaging material identified for treating cancer, packaging:(i) an anti-EGFR antibody comprising the CDR sequences of anti EGFR 565 (CNCM Deposit Number I-4262); and(ii) an anti-ErbB-2 antibody comprising the CDR sequences of anti ErbB-2 L431 (CNCM Deposit Number I-4115), anti ErbB-2 L26 (CNCM Deposit Number I-4113) or anti ErbB-2 N12 (CNCM Deposit Number I-4112),or(iii) an anti-EGFR antibody comprising the CDR sequences of anti EGFR 111 (CNCM Deposit Number I-4261); and(iv) an anti-ErbB-2 antibody comprising the CDR sequences of anti ErbB-2 L431 (CNCM Deposit Number I-4115).Also provided are pharmaceutical compositions and methods of using the above antibodies as well as other antibody combinations for the treatment of cancer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充